Verrica Pharmaceuticals (VRCA)
Commercializes YCANTH for molluscum while developing additional dermatology treatments.
$4.72
After hours+0.01 (+0.21%)
At close$4.71(+4.90%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
in 52 days
EPS estimate
−$0.50
Revenue estimate
$6.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$2.40−$1.00$0.02−$0.03−$0.51−$0.41−$0.62Pending
Estimate−$0.32−$1.23−$0.70−$1.14−$0.43−$0.59−$0.39−$0.50
Surprise−650.0%+19.0%+102.9%+97.4%−18.6%+30.5%−60.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$344.0K$3.4M$12.7M$14.3M$5.1M$5.0M$5.9MPending
Estimate$1.0M$2.5M$4.3M$9.8M$4.5M$4.5M$5.7M$6.4M
Surprise−67.0%+35.7%+197.7%+47.1%+12.7%+11.3%+2.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.12 | — | — |
| Sep 2027 | −$0.31 | — | — |
| Jun 2027 | −$0.44 | — | — |
| Mar 2027 | −$0.30 | — | — |
| Dec 2026 | −$0.48 | — | — |
| Nov 2026 | −$0.50 | — | — |
| Aug 2026 | −$0.39 | −$0.62 | −60.0% |
| May 2026 | −$0.59 | −$0.41 | +30.5% |
| Mar 2026 | −$0.43 | −$0.51 | −18.6% |
| Nov 2025 | −$1.14 | −$0.03 | +97.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.12 | — | — | $11.8M | — | — | — |
| Sep 2027 | −$0.31 | — | — | $10.4M | — | — | — |
| Jun 2027 | −$0.44 | — | — | $9.0M | — | — | — |
| Mar 2027 | −$0.30 | — | — | $7.1M | — | — | — |
| Dec 2026 | −$0.48 | — | — | $7.5M | — | — | — |
| Nov 13, 2026 | −$0.50 | — | — | $6.4M | — | — | — |
| Aug 6, 2026 | −$0.39 | −$0.62 | −60.0% | $5.7M | $5.9M | +2.2% | −5.2% |
| May 12, 2026 | −$0.59 | −$0.41 | +30.5% | $4.5M | $5.0M | +11.3% | +3.1% |
| Mar 11, 2026 | −$0.43 | −$0.51 | −18.6% | $4.5M | $5.1M | +12.7% | +4.7% |
| Nov 14, 2025 | −$1.14 | −$0.03 | +97.4% | $9.8M | $14.3M | +47.1% | +1.6% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 13, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 2, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 7, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 13, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| Jun 15, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |